<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antihypertensive drugs for outpatient management of chronic hypertension for infants, children, and adolescents</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antihypertensive drugs for outpatient management of chronic hypertension for infants, children, and adolescents</h1>
<div class="graphic"><div class="figure"><div class="ttl">Antihypertensive drugs for outpatient management of chronic hypertension for infants, children, and adolescents</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup width="10%"></colgroup><colgroup span="2" width="20%"></colgroup><colgroup width="10%"></colgroup><colgroup width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Drug</td> <td class="subtitle1">Age</td> <td class="subtitle1">Initial oral dose</td> <td class="subtitle1">Maximal oral dose per day</td> <td class="subtitle1">Dosing interval</td> <td class="subtitle1">Formulations</td> </tr> <tr> <td class="subtitle2_left" colspan="6">ACE inhibitors</td> </tr> <tr class="divider_bottom"> <td class="indent1" colspan="6"><strong>Contraindications:</strong> Pregnancy, angioedema.<br/> <strong>Common adverse effects:</strong> Cough, headache, dizziness, asthenia.<br/> <strong>Severe adverse effects:</strong> Hyperkalemia, acute kidney injury, angioedema, fetal toxicity.</td> </tr> <tr> <td class="indent1">Benazepril</td> <td>≥6 years*</td> <td>0.2 mg/kg per day (up to 10 mg per day)</td> <td>0.6 mg/kg (up to 40 mg)</td> <td>Daily.</td> <td> <p>Tablet: 5, 10, 20, 40 mg (generic).</p> Extemporaneous liquid: 2 mg/mL.</td> </tr> <tr> <td class="indent1" rowspan="2">Captopril<sup>¶</sup></td> <td>Infants</td> <td>0.05 mg/kg per dose</td> <td>6 mg/kg</td> <td>Daily to 4 times a day.</td> <td rowspan="2"> <p>Tablet: 12.5, 25, 50, 100 mg (generic).</p> Extemporaneous liquid: 1 mg/mL.</td> </tr> <tr> <td>Children</td> <td>0.5 mg/kg per dose</td> <td>6 mg/kg</td> <td>Three times a day.</td> </tr> <tr> <td class="indent1">Enalapril</td> <td>≥1 month*</td> <td>0.08 mg/kg per day (up to 5 mg per day)</td> <td>0.6 mg/kg (up to 40 mg)</td> <td>Daily to twice a day.</td> <td> <p>Tablet: 2.5, 5, 10, 20 mg (generic).</p> Solution: 1 mg/mL.</td> </tr> <tr> <td class="indent1" rowspan="3">Fosinopril</td> <td>≥6 years</td> <td rowspan="2">0.1 mg/kg per day (up to 5 mg per day)</td> <td rowspan="2">40 mg</td> <td rowspan="3">Daily.</td> <td rowspan="3">Tablet: 10, 20, 40 mg (generic).</td> </tr> <tr> <td>&lt;50 kg</td> </tr> <tr> <td>≥50 kg*</td> <td>5 mg per day</td> <td>40 mg</td> </tr> <tr> <td class="indent1">Lisinopril</td> <td>≥6 years*</td> <td>0.07 mg/kg per day (up to 5 mg per day)</td> <td>0.6 mg/kg (up to 40 mg)</td> <td>Daily.</td> <td> <p>Tablet: 2.5, 5, 10, 20, 30, 40 mg (generic).</p> Solution: 1 mg/mL.</td> </tr> <tr> <td class="indent1">Ramipril<sup>¶</sup></td> <td>NA</td> <td>1.6 mg/m<sup>2</sup> per day</td> <td>6 mg/m<sup>2</sup> </td> <td>Daily.</td> <td>Capsule: 1.25, 2.5, 5, 10 mg (generic).</td> </tr> <tr class="divider_bottom"> <td class="indent1">Quinapril</td> <td>NA</td> <td>5 mg per day</td> <td>80 mg </td> <td>Daily.</td> <td>Tablet: 5, 10, 20, 40 mg (generic).</td> </tr> <tr> <td class="subtitle2_left" colspan="6">ARBs</td> </tr> <tr class="divider_bottom"> <td class="indent1" colspan="6"><strong>Contraindications:</strong> Pregnancy.<br/> <strong>Common adverse effects:</strong> Headache, dizziness.<br/> <strong>Severe adverse effects:</strong> Hyperkalemia, acute kidney injury, fetal toxicity.</td> </tr> <tr> <td class="indent1" rowspan="4">Candesartan</td> <td>1 to 5 years*</td> <td rowspan="2">0.02 mg/kg per day (up to 4 mg per day)</td> <td rowspan="2">0.4 mg/kg (up to 16 mg)</td> <td rowspan="4">Daily to twice a day.</td> <td rowspan="4"> <p>Tablet: 4, 8, 16, 32 mg.</p> Extemporaneous liquid: 1 mg/mL.</td> </tr> <tr> <td>≥6 years*</td> </tr> <tr> <td>&lt;50 kg</td> <td>4 mg per day</td> <td>16 mg </td> </tr> <tr> <td>≥50 kg</td> <td>8 mg per day</td> <td>32 mg </td> </tr> <tr> <td class="indent1" rowspan="2">Irbesartan</td> <td>6 to 12 years</td> <td>75 mg per day</td> <td>150 mg </td> <td rowspan="2">Daily.</td> <td rowspan="2">Tablet: 75, 150, 300 mg (generic).</td> </tr> <tr> <td>≥13 years</td> <td>150 mg per day</td> <td>300 mg </td> </tr> <tr> <td class="indent1">Losartan</td> <td>≥6 years*</td> <td>0.7 mg/kg (up to 50 mg)</td> <td>1.4 mg/kg (up to 100 mg)</td> <td>Daily.</td> <td> <p>Tablet: 25, 50, 100 mg (generic).</p> Extemporaneous liquid: 2.5 mg/mL.</td> </tr> <tr> <td class="indent1" rowspan="3">Olmesartan</td> <td>≥6 years*</td> <td>NA</td> <td>NA</td> <td rowspan="3">Daily.</td> <td rowspan="3"> <p>Tablet: 5, 20, 40 mg.</p> Extemporaneous liquid: 2 mg/mL.</td> </tr> <tr> <td>&lt;35 kg</td> <td>10 mg</td> <td>20 mg</td> </tr> <tr> <td>≥35 kg</td> <td>20 mg</td> <td>40 mg</td> </tr> <tr class="divider_bottom"> <td class="indent1">Valsartan</td> <td>≥1 years*</td> <td>1.3 mg/kg (up to 40 mg)</td> <td>2.7 mg/kg (up to 160 mg)</td> <td>Daily.</td> <td> <p>Tablet: 40, 80, 160, 320 mg (generic).</p> Extemporaneous liquid: 4 mg/mL.</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Thiazide diuretics</td> </tr> <tr class="divider_bottom"> <td class="indent1" colspan="6"><strong>Contraindications:</strong> Anuria.<br/> <strong>Common adverse effects:</strong> Dizziness, hypokalemia.<br/> <strong>Severe adverse effects:</strong> Cardiac dysrhythmias, cholestatic jaundice, new onset diabetes mellitus, pancreatitis.</td> </tr> <tr> <td class="indent1">Chlorthalidone</td> <td>Children</td> <td>0.3 mg/kg</td> <td>2 mg/kg (50 mg)</td> <td>Daily.</td> <td>Tablet: 25, 50, 100 mg (generic).</td> </tr> <tr> <td class="indent1">Chlorothiazide</td> <td>Children*</td> <td>10 mg/kg per day</td> <td>20 mg/kg (up to 375 mg per day)</td> <td>Daily to twice a day.</td> <td> <p>Tablet: 250, 500 mg (generic).</p> <p>Suspension: 250/5 mL.</p> Extemporaneous liquid: 1 mg/mL.</td> </tr> <tr class="divider_bottom"> <td class="indent1">Hydrochlorothiazide</td> <td>Children*</td> <td>1 mg/kg per day</td> <td>2 mg/kg (up to 37.5 mg)</td> <td>Daily to twice a day.</td> <td>Tablet: 12.5, 25, 50 mg.</td> </tr> <tr> <td class="subtitle2_left" colspan="6">Calcium channel blockers</td> </tr> <tr class="divider_bottom"> <td class="indent1" colspan="6"><strong>Contraindications:</strong> Hypersensitivity to CCBs.<br/> <strong>Common adverse effects:</strong> Flushing, peripheral edema, dizziness.<br/> <strong>Severe adverse effects:</strong> Angioedema.</td> </tr> <tr> <td class="indent1" rowspan="2">Amlodipine</td> <td>1 to 5 years</td> <td>0.1 mg/kg</td> <td>0.6 mg/kg (up to 5 mg)</td> <td rowspan="2">Daily.</td> <td rowspan="2"> <p>Tablet: 2.5, 5, 10 mg.</p> Extemporaneous liquid: 1 mg/mL.</td> </tr> <tr> <td>≥6 years*</td> <td>2.5 mg</td> <td>10 mg</td> </tr> <tr> <td class="indent1">Felodipine</td> <td>≥6 years</td> <td>2.5 mg</td> <td>10 mg</td> <td>Daily.</td> <td>Tablet (extended release): 2.5, 5, 10 mg (generic).</td> </tr> <tr> <td class="indent1">Isradipine</td> <td>Children</td> <td>0.05 to 0.1 mg/kg</td> <td>0.6 mg/kg (up to 10 mg)</td> <td> <p>Capsule: Twice daily to 3 times a day.</p> Tablet (extended release): Daily.</td> <td> <p>Capsule: 2.5, 5 mg.</p> Tablet (extended release): 5, 10 mg.</td> </tr> <tr> <td class="indent1">Nifedipine extended release</td> <td>Children</td> <td>0.2 to 0.5 mg/kg per day</td> <td>3 mg/kg (up to 120 mg)</td> <td>Daily to twice a day.</td> <td>Tablet (extended release): 30, 60, 90 mg (generic).</td> </tr> </tbody></table></div><div class="graphic_footnotes">ACE: angiotensin converting enzyme; NA: not applicable; ARB: angiotensin-receptor blocker; FDA: US Food and Drug Administration.<br/>* FDA pediatric labeling.<br/>¶ Dose per 24 hours should not exceed the usual maximum daily dose in adults.</div><div class="graphic_reference">Reproduced with permission from: Pediatrics, Vol. 140, Page e20171904. Copyright © 2017 by the AAP.</div><div id="graphicVersion">Graphic 71466 Version 16.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
